Waddell & Reed Financial’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q2
Sell
-175,000
Closed -$2.98M 575
2014
Q1
$2.98M Buy
175,000
+75,000
+75% +$1.28M ﹤0.01% 523
2013
Q4
$1.3M Buy
+100,000
New +$1.3M ﹤0.01% 551